Protecting Joints: Inhibiting Structural Damage in PsA With Guselkumab

In this RhAPPcast episode, host Amanda Mixon, PA-C, is joined by Wendy Simmons, PA-C, to discuss the role of guselkumab in inhibiting structural damage in psoriatic arthritis. The conversation explores clinical trial data, real-world experience, and the importance of preventing radiographic progression to preserve long-term joint function. This episode highlights how IL-23 inhibition fits into a domain-based treatment approach, including considerations for skin disease, comorbidities, and overlapping conditions such as inflammatory bowel disease.